ProBioGen Overview
- Founded
-
1994
- Status
-
Acquired/Merged
- Employees
-
250
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
ProBioGen General Information
Description
Provider of contract development and manufacturing services in the field of line engineering, process development and GMP manufacturing of biopharmaceuticals. The company's range of services include production cell line engineering, including media optimization, upstream and downstream process development and analytical services, including sophisticated cell-based bioassays.
Contact Information
Website
www.probiogen.de
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Other Commercial Services
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
- Goethestrasse 54
- 13086 Berlin
- Germany
+49 030 0000000
ProBioGen Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ProBioGen Patents
ProBioGen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220090142-A1 | Transposase with enhanced insertion site selection properties | Pending | 13-Feb-2019 | 000000000 | |
| EP-3924474-A1 | Transposase with enhanced insertion site selection properties | Pending | 13-Feb-2019 | 000000000 | |
| CA-3126773-A1 | Transposase with enhanced insertion site selection properties | Pending | 13-Feb-2019 | 000000000 | |
| AU-2019429609-A1 | Transposase with enhanced insertion site selection properties | Pending | 13-Feb-2019 | 000000000 | |
| JP-2022523166-A | Transposase with improved insertion site selection characteristics | Pending | 13-Feb-2019 | C12N15/90 |
ProBioGen Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Lutz Hilbrich | Chief Executive Officer | ||
| Volker Sandig Ph.D | Chief Scientific Officer | ||
| Gabriele Schneider | Chief Business Officer |
ProBioGen Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 00000000 | Minapharm Pharmaceuticals | Chairman | 000 0000 |
ProBioGen Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
ProBioGen Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|